| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |